SUPN Supernus Pharmaceuticals Inc

NASDAQ
$28.61

Supernus Pharmaceuticals Inc (SUPN) SEC Filings

Everything SUPN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

100 filings
Date Form Filing
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
8-K Acquisition Disposition · Delisting
8-K Acquisition Disposition · Capital Raise · Debt · Delisting · Executive Change · Governance Change · Material Agreement · Other · Reg Fd
10-Q
8-K Acquisition Disposition · Earnings Release · Guidance Update
8-K Agreement Terminated · Material Agreement
8-K Other Event · Other Reg Fd
8-K Earnings Date Announcement · Earnings Release
8-K Acquisition Disposition
4
4
4
4
4
10-Q
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
4
10-K
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.